Ro Overview
- Founded
-
2017

- Status
-
Private
- Employees
-
831

- Latest Deal Type
-
Series D1
- Latest Deal Amount
-
$150M
- Investors
-
68
Ro General Information
Description
Developer of a direct-to-consumer telehealth platform intended to handle everything from diagnosis to the convenient delivery of medication. The company's platform allows people to get in touch with physicians and has two end-to-end services, one for erectile dysfunction and the other to help people quit smoking, enabling users to get access to free medication delivery and personalized treatment.
Contact Information
Primary Industry
Clinics/Outpatient Services
Other Industries
Other Healthcare Services
Other Healthcare Technology Systems
Primary Office
- 116 West 23rd Street
- 4th Floor
- New York, NY 10011
- United States
Ro Timeline
Ro Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Later Stage VC (Series D1) | 13-Jan-2022 | $150M | 00.000 | 00.00 | Completed | Generating Revenue |
6. Later Stage VC (Series D) | 08-Mar-2021 | 00000 | 00000 | 000 | Completed | Generating Revenue |
5. Later Stage VC (Series C) | 24-Jul-2020 | 00000 | 00000 | 00.00 | Completed | Generating Revenue |
4. Early Stage VC (Series B) | 04-Mar-2019 | 0000 | 00000 | 00000 | Completed | Generating Revenue |
3. Early Stage VC (Series A) | 17-Sep-2018 | 0000 | 000.00 | 00000 | Completed | Generating Revenue |
2. Seed Round | 01-May-2018 | $3.1M | Completed | Generating Revenue | ||
1. Seed Round | 31-Oct-2017 | $3.1M | $3.1M | 000.00 | Completed | Generating Revenue |
Ro Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series D1 | 0,000,000 | 00.000000 | 00.00 | 000.00 | 000.00 | 00 | 000.00 | 0.000 |
Series D | 00,000,000 | 00.000000 | 00.00 | 000.00 | 000.00 | 00 | 000.00 | 0.000 |
Series C3 | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.00 |
Series C2 | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
Series C1 | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
Series B | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series A2 | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series A1 | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
Series A | 44,199,290 | $0.000010 | $0.03 | $0.45 | $0.45 | 1x | $0.45 | 10.26% |
Seed | 31,825,040 | $0.000010 | $0.01 | $0.1 | $0.1 | 1x | $0.1 | 7.39% |
Ro Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a direct-to-consumer telehealth platform intended to handle everything from diagnosis to the convenient del
Clinics/Outpatient Services
New York, NY
831
As of 2022
00.000
0.00
0000-00-00
00000000000
00.000
Ro Competitors (37)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Nurx | Venture Capital-Backed | San Francisco, CA | 000 | 00000 | 000000&0 | 00000 |
00000000 | Venture Capital-Backed | Denver, CO | 00 | 0000 | 0000000000 0 | 0000 |
000000 00 000000 | Private Equity-Backed | San Francisco, CA | 000 | 00000 | 000000000000 | 00000 |
000000000 | Formerly VC-backed | San Francisco, CA | 000 | 000.00 | 000000&0 | 000.00 |
0000 | Venture Capital-Backed | Pacific Palisades, CA | 000 | 00000 | 00000000000 | 00000 |
Ro Executive Team (7)
Ro Board Members (3)
Name | Representing | Role | Since |
---|---|---|---|
Alexis Ohanian Sr. | Initialized Capital Management | Board Member | 000 0000 |
Hemant Taneja | General Catalyst | Board Member | 000 0000 |
Richard Heitzmann | FirstMark Capital | Board Member | 000 0000 |
Ro Signals
Ro Investors (68)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Litani Ventures | Family Office | Minority | 000 0000 | 000000 0 | |
Vine Capital Management | Venture Capital | Minority | 000 0000 | 000000 0 | |
Wanxiang Healthcare Investments | Venture Capital | Majority | 000 0000 | 000000 0 | |
Altimeter Capital Management | Venture Capital | Minority | 000 0000 | 000000 0 | |
Andreessen Horowitz | Venture Capital | Minority | 000 0000 | 000000 0 |
Ro Acquisitions (6)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000 | 01-Mar-2022 | 0000000000 | 00000 | Other Devices and Supplies | 000000000 |
000 (00000000 | 30-Jun-2021 | 0000000000 | 0000 | Laboratory Services (Healthcare) | 000000000 |
000000 000000 | 19-May-2021 | 0000000000 | 00000 | Other Devices and Supplies | 000000000 |
00000000 | 09-Dec-2020 | 0000000000 | 0000 | Medical Supplies | |
Workpath | 08-Dec-2020 | Merger/Acquisition | Outcome Management (Healthcare) | 000000000 |
Ro Subsidiaries (4)
Company Name | Industry | Location | Founded |
---|---|---|---|
Kit (Laboratory Services (Healthcare)) | Laboratory Services (Healthcare) | San Francisco, CA | 2020 |
000000 000000000 | Other Devices and Supplies | San Francisco, CA | 0000 |
00000000 | Outcome Management (Healthcare) | Richmond, VA | 0000 |
00000000 | IT Consulting and Outsourcing | New York, NY | 0000 |